#USA #Rockville #Insilica #ToxIndex #ProtoPRED

Insilica and ProtoQSAR's Integration of ProtoPRED® into ToxIndex: A Game Changer in Chemical Safety Evaluation

In a significant development for chemical safety assessments, Insilica, Inc., a pioneer in chemical safety intelligence, has announced the integration of ProtoPRED® with their ToxIndex platform in collaboration with ProtoQSAR SL, specialists in computational chemistry. This partnership introduces over 60 predictive models that utilize a streamlined, containerized deployment model within ToxIndex, empowering faster, more reliable evaluations of chemical hazards.

Overview of the Integration

The integration facilitates the deployment of ProtoPRED®'s predictive models in a manner that enhances the overall efficiency of in silico assessments. By maintaining a controlled customer infrastructure, companies can protect sensitive chemical structures, ensuring confidentiality even while using advanced assessment tools. Dr. Tom Luechtefeld, CEO of Insilica, highlights that this collaboration ultimately allows safety teams to evaluate candidate chemicals in mere minutes, an essential capability as regulatory bodies globally shift towards more modern, non-animal testing methodologies.

The Predictive Models of ProtoPRED®

The ProtoPRED® suite encompasses various modules tailored to meet critical regulatory demands:

• - ProtoICH: Focused on impurity analysis in pharmaceuticals (ICH M7)
• - ProtoREACH: Facilitating international regulatory assessments (e.g., EU REACH, K-REACH)
• - ProtoADME: Characterizing drug absorption and metabolism
• - ProtoPHYSCHEM: Describing chemical and physical properties
• - ProtoTOX: Predicting toxicity levels across organ systems
• - ProtoECO: Evaluating ecotoxicity and environmental fate
• - ProtoED: Assessing endocrine disruption potential
• - ProtoNANO: Ensuring safety in nanomaterials
• - GenoITS: Providing integrated assessments of genotoxicity

The breadth of these modules signifies a profound enhancement in the tools available to safety assessment teams, who are increasingly under pressure to deliver quick and effective evaluations without resorting to animal testing.

Enhancing Regulatory Processes

The integration streamlines the process of regulatory submissions by providing validated predictive models directly within an AI-driven workflow. This is crucial for teams looking to meet regulatory standards efficiently. Dr. Rafael Gozalbes, CEO of ProtoQSAR, notes that the collaboration allows for rapid access to validated models that can significantly reduce the time and resources required for critical regulatory submissions.

Availability and Business Model

ProtoPRED® is now accessible to corporate clients of ToxIndex through an annual licensing agreement, offering unlimited predictions without additional charges per user or consultation. This model democratizes access to advanced predictive analytics, allowing more organizations to leverage these sophisticated tools in their chemical safety assessments.

About the Companies

Insilica, Inc.
Located in Rockville, Maryland, Insilica develops a pioneering platform that consolidates chemical hazard databases and models to facilitate risk assessments that do not rely on animal testing.

ProtoQSAR SL
Based in Valencia, Spain, ProtoQSAR has over 15 years of experience in creating proprietary models in the field of predictive toxicology and computational chemistry, focusing on applications in pharmacology, cosmetics, and agrochemicals.

Conclusion

The innovative collaboration between Insilica and ProtoQSAR is set to revolutionize the landscape of chemical safety evaluation. By embracing advanced predictive models and AI-driven methodologies, organizations can now conduct assessments that are not only faster and more efficient but also compliant with modern regulatory standards. As the demand for rapid and reliable chemical safety data continues to rise, partnerships like these will play a crucial role in advancing public health and environmental safety.